TYMS and neoplasm: Using RNA-sequencing data from The Cancer Genome Atlas, we observed a significantly higher expression of TYMS, TK-1, and SLC29A1 in tumor tissue (n = 371) than in adjacent nonmalignant tissue (n = 50; P < 0.05) (Supplemental Figs. 1A–1C).